Charlotte Eldjarn

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
UNLABELLED In all reported clinical studies with (18)F-FDG-labeled leukocytes, heparin was used as an anticoagulant during labeling. Theoretically, the substitution of heparin with citrate should be advantageous. METHODS Blood from healthy controls was sampled in duplicate, anticoagulated with citrate or heparin, and labeled with (18)F-FDG, and the(More)
  • 1